Rani Therapeutics RANI 深 沪
等待开盘 03-30 09:30:00 美东时间
0.8106
-0.269
-24.94%
华盛通- 最 高1.06
- 今 开1.05
- 成交量 365.85万股
- 最 低 0.81
- 昨 收 1.08
- 总市值 9849.73万
- 52周最高 3.87
- 市盈率 静 --
- 换手率 3.01%
- 52周最低 0.387
- 委 比 58.69%
- 总股本 1.22亿
- 历史最高 36.27
- 量 比 2.87
- 振 幅 23.15%
- 历史最低 0.387
- 每 手 1
- 风险率 0.51%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 能源股再或大行青睐！康菲石油、雪铁龙、埃克森美孚、响尾蛇能源等获上调目标价；Unity评级分歧大，大摩、美银上调，富国银行下调
今日重点评级关注：花旗：维持Biomea Fusion"买入"评级，目标价从6美元升至7美元；Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.75美元升至8.25美元
今天 11:49
HC Wainwright & Co. Reiterates Buy on Rani Therapeutics Hldgs, Maintains $11 Price Target
HC Wainwright & Co. analyst Brandon Folkes reiterates Rani Therapeutics Hldgs (NASDAQ:RANI) with a Buy and maintains $11 price target.
03-27 18:50
Rani Therapeutics Hldgs Q4 EPS $(0.07) Misses $(0.06) Estimate, Sales $1.461M Miss $5.000M Estimate
Rani Therapeutics Hldgs (NASDAQ:RANI) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.06) by 22.81 percent. This is a 74.07 percent increase over losses of $(0.27) per
03-27 04:06
Earnings Scheduled For March 26, 2026
Companies Reporting Before The Bell • ProShares UltraShort Russell2000 (NYSE:TW...
03-26 19:11
美股夜盘 | Southland Holdings, Inc.涨49.24%，Tempest Therapeutics, Inc.涨36.21%
Southland Holdings, Inc.涨49.24%；Tempest Therapeutics, Inc.涨36.21%；Rani Therapeutics涨22.81%
03-26 15:01
美股夜盘 | Southland Holdings, Inc.涨53.03%，Navan, Inc. Class A涨26.45%
Southland Holdings, Inc.涨53.03%；Navan, Inc. Class A涨26.45%；Rani Therapeutics涨22.81%
03-26 13:03
Rani Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results
Rani Therapeutics plans to release its Q4 and full-year 2025 financial results on March 26, 2026, followed by a conference call/webcast at 4:30 p.m. ET. The company, which specializes in oral delivery of biologics via its RaniPill® technology, will provide a business update during the call. The webcast can be accessed through its investor relations website, with a replay available post-call.
03-19 20:05
美股大行评级 | 瑞穗上调英伟达、谷歌、美光科技、SanDisk多家科技股目标价；中金首予诺和诺德"跑赢大市"评级，目标价73.5美元
今日重点评级关注：Needham：维持Cartesian Therapeutics"买入"评级，目标价从40美元升至42美元；Piper Sandler：维持Acrivon Therapeutics"超配"评级，目标价从6美元升至8美元
01-12 14:09
Rani Therapeutics Initiated Phase 1 Trial of RT-114, an Orally Administered Ranipill Capsule Containing GLP-1/GLP-2 Dual Agonist, PG-102, for Obesity
PG-102 is a fc-fusion protein conjugated GLP-1/GLP-2 dual agonist in development by ProGen Co., Ltd. ("ProGen"). ProGen recently announced preclinical and clinical data, at the 2025 European Association for the Study of
01-08 20:14
